Lobuprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C25H33ClN2O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X2T6O1TUNX, chemically known as propanoic acid, 2-(4-(2-methylpropyl)phenyl)-, 2-(4-(3-chlorophenyl)-1-piperazinyl)ethyl ester, hydrochloride but generally known as lobuprofen, which bears US NIH Compound Identifier 65842. European Medicines Agency schedules Lobuprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08545MIG. The term LOBUPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). LOBUPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lobuprofen under HS 29335995 and SITC 51576. As of Q4 2014, LOBUPROFEN remains the US FDA Preferred Term for this commodity. Lobuprofen bears US NLM identifiers UMLS ID C2825253 and NCI Concept Code C80559. SMILES: CLC1C(N2CCN(CC2)CCOC(=O)C(C2CCC(CC(C)C)CC2)C)CCCC1.CL.